Phase I Study of XZ120 in Malignant Tumors

NCT06206915 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancies

Interventions

DRUG: XZ120 injection

Sponsor

Shandong New Time Pharmaceutical Co., LTD

Collaborators

[object Object]
[object Object]